 | PKG | Name: | (3S)-3-[2-(benzenecarbonyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]-3-(1-ethyl-4-methyl-1H-benzotriazol-5-yl)propanoic acid | Formula: | C28 H28 N4 O3 | SMILES: | c12CCN(Cc1cc(cc2)C(c4c(C)c3nnn(c3cc4)CC)CC(O)=O)C(=O)c5ccccc5 | InChi: | InChI=1S/C28H28N4O3/c1-3-32-25-12-11-23(18(2)27(25)29-30-32)24(16-26(33)34)21-10-9-19-13-14-31(17-22(19)15-21)28(35)20-7-5-4-6-8-20/h4-12,15,24H,3,13-14,16-17H2,1-2H3,(H,33,34)/t24-/m0/s1 | Definition date: | 2019-08-12 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | (3S)-3-[2-(benzenecarbonyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]-3-(1-ethyl-4-methyl-1H-benzotriazol-5-yl)propanoic acid |
|
 | HS4 | Name: | N-oxidanyl-2-[(4-phenylphenyl)sulfonylamino]ethanamide | Formula: | C14 H14 N2 O4 S | SMILES: | O=NC(=O)CNS(=O)(=O)c2ccc(c1ccccc1)cc2 | InChi: | InChI=1S/C14H14N2O4S/c17-14(16-18)10-15-21(19,20)13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,15,18H,10H2,(H,16,17) | Definition date: | 2008-11-04 | Last modified: | 2020-01-07 | Identifier: | N~2~-(biphenyl-4-ylsulfonyl)-N-oxoglycinamide |
|
 | SFH | Name: | 5'-O-[(pyridine-3-carbonyl)sulfamoyl]adenosine | Formula: | C16 H17 N7 O7 S | SMILES: | C3(n1c2c(nc1)c(N)ncn2)OC(C(C3O)O)COS(NC(c4cnccc4)=O)(=O)=O | InChi: | InChI=1S/C16H17N7O7S/c17-13-10-14(20-6-19-13)23(7-21-10)16-12(25)11(24)9(30-16)5-29-31(27,28)22-15(26)8-2-1-3-18-4-8/h1-4,6-7,9,11-12,16,24-25H,5H2,(H,22,26)(H2,17,19,20)/t9-,11-,12-,16-/m1/s1 | Definition date: | 2019-10-09 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 5'-O-[(pyridine-3-carbonyl)sulfamoyl]adenosine |
|
 | EGE | Name: | 4-azanyl-2-oxidanyl-5-[(~{E})-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid | Formula: | C18 H15 N5 O5 S | SMILES: | Nc1cc(O)c(cc1N=Nc2ccc(cc2)[S](=O)(=O)Nc3ccccn3)C(O)=O | InChi: | InChI=1S/C18H15N5O5S/c19-14-10-16(24)13(18(25)26)9-15(14)22-21-11-4-6-12(7-5-11)29(27,28)23-17-3-1-2-8-20-17/h1-10,24H,19H2,(H,20,23)(H,25,26)/b22-21+ | Definition date: | 2018-03-18 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 4-azanyl-2-oxidanyl-5-[(~{E})-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid |
|
 | EGH | Name: | (4~{R})-4-(5-bromanyl-2-fluoranyl-phenyl)-5,6,7-trimethoxy-3,4-dihydro-1~{H}-quinolin-2-one | Formula: | C18 H17 Br F N O4 | SMILES: | COc1cc2NC(=O)C[CH](c3cc(Br)ccc3F)c2c(OC)c1OC | InChi: | InChI=1S/C18H17BrFNO4/c1-23-14-8-13-16(18(25-3)17(14)24-2)11(7-15(22)21-13)10-6-9(19)4-5-12(10)20/h4-6,8,11H,7H2,1-3H3,(H,21,22)/t11-/m0/s1 | Definition date: | 2018-03-18 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | (4~{R})-4-(5-bromanyl-2-fluoranyl-phenyl)-5,6,7-trimethoxy-3,4-dihydro-1~{H}-quinolin-2-one |
|
 | EGN | Name: | 4-[2-(4-cyclohexylpiperazin-4-ium-1-yl)-2-oxidanylidene-ethyl]sulfanyl-1-ethyl-quinolin-2-one | Formula: | C23 H32 N3 O2 S | SMILES: | CCN1C(=O)C=C(SCC(=O)N2CC[NH+](CC2)C3CCCCC3)c4ccccc14 | InChi: | InChI=1S/C23H31N3O2S/c1-2-26-20-11-7-6-10-19(20)21(16-22(26)27)29-17-23(28)25-14-12-24(13-15-25)18-8-4-3-5-9-18/h6-7,10-11,16,18H,2-5,8-9,12-15,17H2,1H3/p+1 | Definition date: | 2018-03-19 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 4-[2-(4-cyclohexylpiperazin-4-ium-1-yl)-2-oxidanylidene-ethyl]sulfanyl-1-ethyl-quinolin-2-one |
|
 | FXH | Name: | 1-[(dimethylamino)methyl]naphthalen-2-ol | Formula: | C13 H15 N O | SMILES: | CN(C)Cc1c(O)ccc2ccccc12 | InChi: | InChI=1S/C13H15NO/c1-14(2)9-12-11-6-4-3-5-10(11)7-8-13(12)15/h3-8,15H,9H2,1-2H3 | Definition date: | 2018-08-13 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | 1-[(dimethylamino)methyl]naphthalen-2-ol |
|
 | N2V | Name: | N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine | Formula: | C50 H47 Cl2 N3 O6 | SMILES: | c2(ccc(OCc1cc(Cl)c(cc1)Cl)cc2)C7Oc6cc5CN(C(C(=O)NC(C(=O)O)Cc4ccc(c3c(c(C)ncc3)C)cc4)Cc5cc6OC7)C(c8ccccc8)CC | InChi: | InChI=1S/C50H47Cl2N3O6/c1-4-44(35-8-6-5-7-9-35)55-27-38-26-47-46(60-29-48(61-47)36-15-17-39(18-16-36)59-28-33-12-19-41(51)42(52)22-33)25-37(38)24-45(55)49(56)54-43(50(57)58)23-32-10-13-34(14-11-32)40-20-21-53-31(3)30(40)2/h5-22,25-26,43-45,48H,4,23-24,27-29H2,1-3H3,(H,54,56)(H,57,58)/t43-,44-,45-,48+/m0/s1 | Definition date: | 2019-05-01 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | N-{(3S,8S)-3-{4-[(3,4-dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine |
|
 | LMY | Name: | ~{N}-[3-[[2-cyano-4-methyl-5-[[4-[[2-(methylamino)-6-[2,2,2-tris(fluoranyl)ethyl]thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]methyl]-1-bicyclo[1.1.1]pentanyl]methanamide | Formula: | C32 H35 F3 N8 O S | SMILES: | CNc1nc(NC2CCN(CC2)Cc3ccc4n(CC56CC(C5)(C6)NC=O)c(cc4c3C)C#N)c7cc(CC(F)(F)F)sc7n1 | InChi: | InChI=1S/C32H35F3N8OS/c1-19-20(3-4-26-24(19)9-22(12-36)43(26)17-30-14-31(15-30,16-30)38-18-44)13-42-7-5-21(6-8-42)39-27-25-10-23(11-32(33,34)35)45-28(25)41-29(37-2)40-27/h3-4,9-10,18,21H,5-8,11,13-17H2,1-2H3,(H,38,44)(H2,37,39,40,41)/t30-,31+ | Definition date: | 2019-03-04 | Last modified: | 2020-01-03 | Release date: | 2020-01-08 | Identifier: | ~{N}-[3-[[2-cyano-4-methyl-5-[[4-[[2-(methylamino)-6-[2,2,2-tris(fluoranyl)ethyl]thieno[2,3-d]pyrimidin-4-yl]amino]piperidin-1-yl]methyl]indol-1-yl]methyl]-1-bicyclo[1.1.1]pentanyl]methanamide |
|
 | Q6S | Name: | N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-2'-methyl[1,1'-biphenyl]-3-carboxamide | Formula: | C28 H29 F N4 O3 | SMILES: | N(Cc1cc(cc(c1)OC)OC)C(=O)c3cc(CN2C(/N(C)C=C2)=N)cc(c3)c4ccc(cc4C)F | InChi: | InChI=1S/C28H29FN4O3/c1-18-9-23(29)5-6-26(18)21-10-20(17-33-8-7-32(2)28(33)30)11-22(14-21)27(34)31-16-19-12-24(35-3)15-25(13-19)36-4/h5-15,30H,16-17H2,1-4H3,(H,31,34)/b30-28+ | Definition date: | 2019-09-26 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | N-[(3,5-dimethoxyphenyl)methyl]-4'-fluoro-5-{[(2E)-2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl]methyl}-2'-methyl[1,1'-biphenyl]-3-carboxamide |
|
 | QJ1 | Name: | methyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate | Formula: | C11 H15 N O2 S2 | SMILES: | c1(sccc1)C2CCN(C(OC)=O)CCS2 | InChi: | InChI=1S/C11H15NO2S2/c1-14-11(13)12-5-4-10(16-8-6-12)9-3-2-7-15-9/h2-3,7,10H,4-6,8H2,1H3/t10-/m0/s1 | Definition date: | 2019-11-04 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | methyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate |
|
 | QJA | Name: | 1-[(7S)-7-(thiophen-2-yl)-6,7-dihydro-1,4-thiazepin-4(5H)-yl]ethan-1-one | Formula: | C11 H13 N O S2 | SMILES: | CC(N1C=CSC(CC1)c2sccc2)=O | InChi: | InChI=1S/C11H13NOS2/c1-9(13)12-5-4-11(15-8-6-12)10-3-2-7-14-10/h2-3,6-8,11H,4-5H2,1H3/t11-/m0/s1 | Definition date: | 2019-11-04 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 1-[(7S)-7-(thiophen-2-yl)-6,7-dihydro-1,4-thiazepin-4(5H)-yl]ethan-1-one |
|
 | QKD | Name: | ethyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate | Formula: | C12 H17 N O2 S2 | SMILES: | C2N(C(OCC)=O)CCC(c1sccc1)SC2 | InChi: | InChI=1S/C12H17NO2S2/c1-2-15-12(14)13-6-5-11(17-9-7-13)10-4-3-8-16-10/h3-4,8,11H,2,5-7,9H2,1H3/t11-/m0/s1 | Definition date: | 2019-11-06 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | ethyl (7S)-7-(thiophen-2-yl)-1,4-thiazepane-4-carboxylate |
|
 | B7O | Name: | ~{N}-[4-[(4-~{tert}-butylphenyl)carbonylamino]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide | Formula: | C26 H26 N2 O4 | SMILES: | CC(C)(C)c1ccc(cc1)C(=O)Nc2ccc(NC(=O)c3ccc4OCCOc4c3)cc2 | InChi: | InChI=1S/C26H26N2O4/c1-26(2,3)19-7-4-17(5-8-19)24(29)27-20-9-11-21(12-10-20)28-25(30)18-6-13-22-23(16-18)32-15-14-31-22/h4-13,16H,14-15H2,1-3H3,(H,27,29)(H,28,30) | Definition date: | 2019-01-18 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | ~{N}-[4-[(4-~{tert}-butylphenyl)carbonylamino]phenyl]-2,3-dihydro-1,4-benzodioxine-6-carboxamide |
|
 | B7U | Name: | (2S)-2-phenyl-N-[(1R)-1-phenylethyl]propanamide | Formula: | C17 H19 N O | SMILES: | O=C(C(C)c1ccccc1)NC(C)c2ccccc2 | InChi: | InChI=1S/C17H19NO/c1-13(15-9-5-3-6-10-15)17(19)18-14(2)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,18,19)/t13-,14+/m0/s1 | Definition date: | 2019-01-21 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | (2S)-2-phenyl-N-[(1R)-1-phenylethyl]propanamide |
|
 | L7Y | Name: | 5-(4-chlorophenyl)-3-({[3-(morpholine-4-carbonyl)phenyl]amino}methyl)pyridin-2(1H)-one | Formula: | C23 H22 Cl N3 O3 | SMILES: | Clc1ccc(cc1)C2=CNC(=O)C(=C2)CNc3cccc(c3)C(N4CCOCC4)=O | InChi: | InChI=1S/C23H22ClN3O3/c24-20-6-4-16(5-7-20)18-12-19(22(28)26-14-18)15-25-21-3-1-2-17(13-21)23(29)27-8-10-30-11-9-27/h1-7,12-14,25H,8-11,15H2,(H,26,28) | Definition date: | 2019-02-11 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 5-(4-chlorophenyl)-3-({[3-(morpholine-4-carbonyl)phenyl]amino}methyl)pyridin-2(1H)-one |
|
 | E7X | Name: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-hydroxyethyl)amino]-2-azaniumyl-butanoate | Formula: | C16 H25 N7 O6 | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CN(CCO)CC[CH]([NH3+])C([O-])=O)[CH](O)[CH]3O | InChi: | InChI=1S/C16H25N7O6/c17-8(16(27)28)1-2-22(3-4-24)5-9-11(25)12(26)15(29-9)23-7-21-10-13(18)19-6-20-14(10)23/h6-9,11-12,15,24-26H,1-5,17H2,(H,27,28)(H2,18,19,20)/t8-,9+,11+,12+,15+/m0/s1 | Definition date: | 2019-11-14 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | (2~{S})-4-[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl-(2-hydroxyethyl)amino]-2-azaniumyl-butanoate |
|
 | KHQ | Name: | 1-[4-[(1~{R})-1-[2-[[5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-tris(fluoranyl)propan-1-one | Formula: | C28 H31 F3 N8 O | SMILES: | C[CH](N1CCN(CC1)C(=O)CC(F)(F)F)c2ccnc(Nc3[nH]c4ccc(cc4n3)c5cnn(CC6CC6)c5)c2 | InChi: | InChI=1S/C28H31F3N8O/c1-18(37-8-10-38(11-9-37)26(40)14-28(29,30)31)20-6-7-32-25(13-20)36-27-34-23-5-4-21(12-24(23)35-27)22-15-33-39(17-22)16-19-2-3-19/h4-7,12-13,15,17-19H,2-3,8-11,14,16H2,1H3,(H2,32,34,35,36)/t18-/m1/s1 | Definition date: | 2019-05-22 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 1-[4-[(1~{R})-1-[2-[[5-[1-(cyclopropylmethyl)pyrazol-4-yl]-1~{H}-benzimidazol-2-yl]amino]pyridin-4-yl]ethyl]piperazin-1-yl]-3,3,3-tris(fluoranyl)propan-1-one |
|
 | KHT | Name: | ~{N}-(cyclopropen-1-ylmethyl)-2-[[4-[[4-[3,3,3-tris(fluoranyl)propanoyl]piperazin-1-yl]methyl]pyridin-2-yl]amino]-1~{H}-benzimidazole-5-carboxamide | Formula: | C25 H26 F3 N7 O2 | SMILES: | FC(F)(F)CC(=O)N1CCN(CC1)Cc2ccnc(Nc3[nH]c4ccc(cc4n3)C(=O)NCC5=CC5)c2 | InChi: | InChI=1S/C25H26F3N7O2/c26-25(27,28)13-22(36)35-9-7-34(8-10-35)15-17-5-6-29-21(11-17)33-24-31-19-4-3-18(12-20(19)32-24)23(37)30-14-16-1-2-16/h1,3-6,11-12H,2,7-10,13-15H2,(H,30,37)(H2,29,31,32,33) | Definition date: | 2019-05-22 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | ~{N}-(cyclopropen-1-ylmethyl)-2-[[4-[[4-[3,3,3-tris(fluoranyl)propanoyl]piperazin-1-yl]methyl]pyridin-2-yl]amino]-1~{H}-benzimidazole-5-carboxamide |
|
 | FTW | Name: | 5-[(4-methoxynaphthalen-1-yl)methyl]-1-[2-[(2-methyl-1-oxidanyl-propan-2-yl)amino]ethyl]-~{N}-(naphthalen-1-ylmethyl)-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridine-3-carboxamide | Formula: | C36 H41 N5 O3 | SMILES: | COc1ccc(CN2CCc3n(CCNC(C)(C)CO)nc(C(=O)NCc4cccc5ccccc45)c3C2)c6ccccc16 | InChi: | InChI=1S/C36H41N5O3/c1-36(2,24-42)38-18-20-41-32-17-19-40(22-27-15-16-33(44-3)30-14-7-6-13-29(27)30)23-31(32)34(39-41)35(43)37-21-26-11-8-10-25-9-4-5-12-28(25)26/h4-16,38,42H,17-24H2,1-3H3,(H,37,43) | Definition date: | 2018-07-27 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 5-[(4-methoxynaphthalen-1-yl)methyl]-1-[2-[(2-methyl-1-oxidanyl-propan-2-yl)amino]ethyl]-~{N}-(naphthalen-1-ylmethyl)-6,7-dihydro-4~{H}-pyrazolo[4,3-c]pyridine-3-carboxamide |
|
 | M9K | Name: | 2-(6-chloranyl-7-cyclopropyl-thieno[3,2-d]pyrimidin-4-yl)sulfanylethanoic acid | Formula: | C11 H9 Cl N2 O2 S2 | SMILES: | OC(=O)CSc1ncnc2c1sc(Cl)c2C3CC3 | InChi: | InChI=1S/C11H9ClN2O2S2/c12-10-7(5-1-2-5)8-9(18-10)11(14-4-13-8)17-3-6(15)16/h4-5H,1-3H2,(H,15,16) | Definition date: | 2019-10-09 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 2-(6-chloranyl-7-cyclopropyl-thieno[3,2-d]pyrimidin-4-yl)sulfanylethanoic acid |
|
 | M9N | Name: | 2-[[(4~{S})-5-chloranyl-6-methyl-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-4-yl]sulfanyl]ethanoic acid | Formula: | C9 H11 Cl N2 O2 S2 | SMILES: | Cc1sc2NCN[CH](SCC(O)=O)c2c1Cl | InChi: | InChI=1S/C9H11ClN2O2S2/c1-4-7(10)6-8(15-2-5(13)14)11-3-12-9(6)16-4/h8,11-12H,2-3H2,1H3,(H,13,14)/t8-/m0/s1 | Definition date: | 2019-10-09 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 2-[[(4~{S})-5-chloranyl-6-methyl-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-4-yl]sulfanyl]ethanoic acid |
|
 | M9T | Name: | 2-[(4-methoxy-2-methyl-phenyl)amino]-7-methyl-9-(4-oxidanylcyclohexyl)purin-8-one | Formula: | C20 H25 N5 O3 | SMILES: | COc1ccc(Nc2ncc3N(C)C(=O)N([CH]4CC[CH](O)CC4)c3n2)c(C)c1 | InChi: | InChI=1S/C20H25N5O3/c1-12-10-15(28-3)8-9-16(12)22-19-21-11-17-18(23-19)25(20(27)24(17)2)13-4-6-14(26)7-5-13/h8-11,13-14,26H,4-7H2,1-3H3,(H,21,22,23)/t13-,14- | Definition date: | 2019-10-09 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 2-[(4-methoxy-2-methyl-phenyl)amino]-7-methyl-9-(4-oxidanylcyclohexyl)purin-8-one |
|
 | MBW | Name: | 7-methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one | Formula: | C18 H20 N8 O2 | SMILES: | CN1C(=O)N(C2CCOCC2)c3nc(Nc4cn5ncnc5cc4C)ncc13 | InChi: | InChI=1S/C18H20N8O2/c1-11-7-15-20-10-21-25(15)9-13(11)22-17-19-8-14-16(23-17)26(18(27)24(14)2)12-3-5-28-6-4-12/h7-10,12H,3-6H2,1-2H3,(H,19,22,23) | Definition date: | 2019-10-10 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | 7-methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one |
|
 | MFE | Name: | ~{N}-[(4-chlorophenyl)methyl]quinazolin-4-amine | Formula: | C15 H12 Cl N3 | SMILES: | Clc1ccc(CNc2ncnc3ccccc23)cc1 | InChi: | InChI=1S/C15H12ClN3/c16-12-7-5-11(6-8-12)9-17-15-13-3-1-2-4-14(13)18-10-19-15/h1-8,10H,9H2,(H,17,18,19) | Definition date: | 2019-10-12 | Last modified: | 2019-12-27 | Release date: | 2020-01-01 | Identifier: | ~{N}-[(4-chlorophenyl)methyl]quinazolin-4-amine |
|